Wall Street Red on Friday Despite Strong Jobs Report

Grifols obtains FDA approval

Author's Avatar
Jul 05, 2019
Article's Main Image

U.S. stocks were bearish on Friday despite the U.S. adding 224,000 nonfarm payroll jobs during the past month, which was higher than estimates of 160,000. The unemployment rate reached 3.7%, 10 basis point higher than expectations of 3.6%. The Dow Jones Industrial Average fell 0.16% to 26,922, the S&P 500 Index declined 0.18% to 2,990 and the Nasdaq Composite Index slid 0.10% to 8,161.

Shares of Grifols S.A. (GRFS, Financial) gained more than 1% on Friday after the U.S. Food and Drug Administration approved Xembify, a new 20% subcutaneous immunoglobulin used to treat primary immunodeficiencies, expanding its product portfolio of plasma-derived medicines. The company will launch the product in the last quarter of 2019. Further, it plans to obtain approval in Canada and Europe.

Gainers

Losers

Global markets

The main European stock markets traded lower. The U.K.'s FTSE 100 dipped 0.66%, France's CAC 40 lost 0.48%, Germany's Dax slid 0.49% and Spain's IBEX 35 fell 0.70%.

In Asia, Japan's Nikkei 225 gained 0.20%, India’s BSE Sensex dropped 0.99%, Hong Kong's Hang Seng retreated 0.07% and China's Shanghai Composite closed 0.19% higher.

Disclosure: The author holds no positions in any stocks mentioned.

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.